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Purpose: To determine the effects of pharmacologically relevant
concentrations of Rhein, the metabolite of Diacerhein, on cell
proliferation rate of both human chondrocytes and synoviocytes.
Methods: Human articular chondrocytes and synoviocytes were
obtained from the knee or hankle of osteoarthritic patients. They
were isolated by enzymatic procedure and cultured as monolay-
ers in DMEM + 10% FCS, either in normal atmosphere (21% O2
for synoviocytes) or in hypoxia (5% O2 for chondrocytes), with
10-6, 10-5, and 10-4M Rhein or the corresponding concentrations
of its vehicle DMSO. [3H] thymidine incorporation was used to
determine Rhein proliferative effects at 24 h, 48 h and one week
incubation times. Cytotoxicity of the drug was also assayed with
a non radioactive assay kit. Nuclear extracts were prepared and
used to detect variation of cell cycle proteins by Western blotting.
Moreover, Rhein effects on apoptosis were investigated through
measurement of caspase activity.
Results: Rhein inhibited the proliferation rate of both chon-
drocytes and synoviocytes in a dose-dependent manner, with
significant decrease of thymidine labeling for 10-5 M Rhein (by
approximately two-fold) and for 10-4 M Rhein (around 5-6 fold).
In the same experimental conditions, no cytotoxicity of the drug
was observed as compared to its vehicle DMSO. Western blots
showed that Rhein modulates expression of cell cycle proteins:
Rhein at 10-4 M decreased p27 expression, but not that p21, nor
cyclin D1 expression.
Conclusions: Previous results indicated that Rhein may reduce
the IL-1β deleterious effects on osteoarthritis cartilage through
inhibition of the expression of degrading enzymes. Here we
showed that Rhein could inhibit proliferation of both synoviocytes
and chondrocytes. Thus, by its antiproliferative properties, this
drug may decrease the development of the inflammatory synovial
tissue that accompanies both OA and RA joint pathologies. Both
its anti-catabolic and anti-proliferative effects may explain its
value for the treatment of joint diseases.
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Purpose: Glucosamine (GlcN) is increasingly being used for its
claimed structure modifying effects in osteoarthritis. Despite this,
the debate on its exact mechanism of action still continues. In
vitro studies have reported conflicting results, probably due to
different culture conditions in these various studies. The aim of
our study was to determine the effects of GlcN under anabolic
and catabolic culture conditions.
Methods: Chondrocytes from 6-12 month old calf MCP joints
were seeded in alginate beads and cultured in low glucose D-
MEM with 10% FCS and 25 μg/ml ascorbic acid 2-phosphate. To
evaluate the effect under anabolic conditions 5 mM glucosamine
hydrochloride (GlcN-HCl) or N-acetyl-glucosamine (N-Ac-GlcN)
were added to the cultures for 14 days after a 3-day pre-culture
period. For the evaluation of the effect of GlcN under catabolic
conditions, alginate beads were treated with 10 ng/ml recombi-
nant human IL-1β on day 8-10, in combination with GlcN-HCl 5
mM from day 6-10. Following this treatment, culturing was con-
tinued for 7 more days. A no supplement condition and GlcN-HCl
pre-treatment only condition were used as controls. Beads were
harvested for analyses of DNA and GAG content at various time
points.
Results: The no supplements control and 5 mM N-Ac-GlcN
showed an increase of GAG content with time during the first 17
days of culture. Addition of 5 mM GlcN-HCl showed a statistically
significant reduced GAG production. The amount of DNA per
bead showed a similar trend.
As expected, addition of IL-1β also led to inhibition of GAG
content. Pre-treatment with GlcN-HCl, reduced the effect of IL-
1β.
Conclusions: This study indicates that GlcN-HCl inhibits an-
abolic and the catabolic process. A possible explanation might
be a direct competition between glucose and GlcN-HCl. At first on
entering the cell, utilizing the same transporter system and sec-
ondly intracellular, since glucose and GlcN are both phosphory-
lated by glucokinase. Phosphorylated GlcN in turn is an allosteric
inhibitor of glucokinase, resulting in extra negative feedback. The
result of this competition might be that less glucose-6-P en-
ters the glycolysis, leading to a depletion of intracellular ATP.
This eventually results in less energy for all kinds of intracellular
processes, like extracellular matrix production and breakdown.
This competition hypothesis was tested by adding more glucose
to the medium and that resulted in normalization of GAG syn-
thesis. An explanation why N-Ac-GlcN does not inhibit matrix
synthesis, may be that it is phosphorylated by a different enzyme
and thus no competition with glucose occurs, while the phospho-
rylated product can be used for GAG synthesis as well. Based
on our results, we propose that the claimed structure modifying
effects of glucosamine might be based on interference with the
energy household of chondrocytes.
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Purpose: To determine the best protocol for the preparation of
a tissue-engineered cartilage to investigate the potential anti-
arthritic and/or anti-osteoarthritic effects of drugs such as Avo-
cado/Soybean Unsaponifiables (ASU).
Methods: Calf articular chondrocytes, seeded in collagen
sponges, were grown in culture for up to 1 month. Cultures
received interleukin (IL)-1b (ranging from 0.1 to 20 ng/ml) at day
14 for 1 to 3 days and/or ASU (ranging from 1 to 10 ug/ml) from
day 2 every day or from day 14 for 1 to 3 days. Analyses of gene
expression for extracellular matrix proteins, collagen-binding inte-
grins, matrix metalloproteinases (MMPs), aggrecanases, TIMPs,
IL-1Ra and Ik-Ba were carried out using real-time polymerase
chain reaction (PCR). Metalloproteinase activities were analysed
in the culture medium using both zymography and fluorogenic
peptide substrates.
Results: We selected a culture for 15 to 18 days with collagen
sponges seeded with 107 chondrocytes showing a minimal cell
proliferation, a maximal sulphated glycosaminoglycan (sGAG)
